NetraMark Holdings (TSE:AIAI) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
NetraMark Holdings has signed a pilot collaboration agreement with a top pharmaceutical company to enhance the development of new autoimmune disorder treatments using its advanced AI technology. The collaboration will leverage NetraAI to analyze genetic data and refine patient subtypes, aiming to unlock novel insights and improve clinical trial outcomes. This partnership underscores NetraMark’s commitment to advancing precision medicine and driving innovation in treatment strategies.
For further insights into TSE:AIAI stock, check out TipRanks’ Stock Analysis page.
